纳米雄黄的抗小鼠原位乳腺癌作用及其机制

中国临床药理学与治疗学 ›› 2013, Vol. 18 ›› Issue (9): 981-987.

纳米雄黄的抗小鼠原位乳腺癌作用及其机制

席晓霞^1,2, 范临兰², 田永刚², 王蓓², 张景科², 程杰², 魏虎来², 吴润¹

¹甘肃农业大学动物医学院,兰州 730070,甘肃;
²兰州大学基础医学院,兰州 730000,甘肃

收稿日期:2012-12-21 修回日期:2013-06-26 发布日期:2013-09-07
通讯作者: 魏虎来,男,教授,博士研究生导师,研究方向:细胞分子生物学。Tel: 0931-8915082 E-mail: weihulai@lzu.edu.cn; 吴润,男,教授,博士研究生导师,研究方向:预防兽医学。Tel: 0931-7631229 E-mail: wurun@gsau.edu.cn
作者简介:席晓霞,女,博士研究生,研究方向:医学实验动物学/兽医学。Tel: 0931-8915394 E-mail: xixx@lzu.edu.cn
基金资助:
甘肃省中医药科学技术研究课题(GZK-2010-17);甘肃省自然科学研究基金计划项目(096RJZA034)资助

The anti-tumor effects and mechanism of Realgar nanoparticles on orthotopic breast cancer in mice

XI Xiao-xia^1,2, FAN Lin-lan², TIAN Yong-gang², WANG Bei², ZHANG Jing-ke², CHENG Jie², WEI Hu-lai², WU Run¹

¹College of Veterinary Medicine, Gansu Agricultural University, Lanzhou 730070, Gansu, China;
²School of Basic Medical Sciences, Lanzhou University, Lanzhou 730000, Gansu, China

Received:2012-12-21 Revised:2013-06-26 Published:2013-09-07

摘要/Abstract

摘要： 目的: 研究纳米雄黄体内体外对小鼠乳腺癌细胞(4T1)的增殖抑制作用及其机制。方法: 以萤火虫荧光素酶(Luciferase, Luc)基因标记小鼠4T1乳腺癌(4T1-Luc)细胞,应用噻唑蓝(MTT)比色法和生物发光法(Bioluminescent method, BLM)检测细胞增殖活性;细胞形态学及Annexin V/PI 双标记法观察细胞凋亡。4T1-Luc细胞接种雌性BALB/c小鼠乳腺脂肪垫制作原位乳腺癌模型,纳米雄黄(4和 8 mg·kg^-1·d^-1)灌胃治疗 20 d,小动物活体成像系统连续动态观察小鼠乳腺肿瘤生长变化,治疗末期处死动物、剥离肿瘤块称重,并制片HE染色和CD₃₄标记观测肿瘤组织内细胞核分裂像、新生血管形成及坏死改变。结果: MTT法和BLM法检测显示 1.56~50 μg/mL 纳米雄黄体外显著抑制 4T1-Luc 细胞的增殖(P<0.05);形态学观察和Annexin V/PI染色显示细胞呈现典型的凋亡改变。体内纳米雄黄呈时间和剂量依赖性地抑制小鼠4T1-Luc原位乳腺癌的生长(P<0.05);肿瘤组织制片观察,经纳米雄黄治疗后肿瘤组织内细胞核分裂像和微小血管显著减少(P<0.01),肿瘤组织内部呈显著的坏死改变。结论: 纳米雄黄体外抑制小鼠乳腺癌4T1细胞增殖和诱导细胞凋亡,并主要通过减低原位肿瘤组织内新生血管的形成而导致肿瘤组织坏死而发挥抗乳腺癌作用。

关键词: 纳米雄黄, 小鼠原位乳腺癌, 活体成像技术

Abstract: AIM: To study the anti-proliferating action of realgar nanoparticles (nano-realgar) on murine orthotopic transplanted breast carcinoma (4T1) in vitro and in vivo.METHODS: The firefly luciferase gene was transferred into murine 4T1 breast cancer cells with a lentiviral vector (4T1-Luc cells). Both MTT colorimetric assay and bioluminescence (BLM) assay was used to detect the cellular cell proliferation, the morphological observation and Annexin V and propidium iodide (Annexin V/PI) double-labeling were employed to assess the cell apoptosis in vitro. The 4T1-Luc cells were orthotopically implanted into the mammary fat pad of female BALB/c mice to establish the orthotopic transplanted model of mouse breast cancer, the tumor-bearing mice were treated with 4 mg·kg^-1·d^-1 and 8 mg·kg^-1·d^-1 nano-realgar, by gavage once a day, for 20 days, respectively, the optical in vivo imaging system was used to continuously and dynamically observe the growth, and at the end of the treatment the animals were sacrificed, and the tumor tissue was removed and weighed. The tumor tissue sections were prepared and stained with HE stain for examination of karyokinesis and necrosis in tumors, and the tumor angiogenesis was observed by CD₃₄ immunocytochemistry.RESULTS: Both MTT and BLM assays showed that 1.56-50 μg/mL nano-realgar significantly inhibited the proliferation of 4T1-Luc cells (P<0.05), and the morphological observation and Annexin V/PI staining displayed the typical apoptotic characteristics in the cells. Nano-realgar significantly inhibited the growth of the mouse 4T1 orthotopic breast cancer in vivo at a time- and dose-dependent manner (P<0.05). The pathological and immunocytochemistry examination showed that after nano-realgar administration, the numbers of mitotic cells and microvessels in tumor tissue markedly reduced, and the extensive necrosis region could be observed at the center of the tumor tissue.CONCLUSION: Realgar nanoparticles significantly inhibits the proliferation of murine 4T1 breast cancer cells and induces to apoptosis in vitro, and plays the anti-tumor action on orthotopic transplanted breast cancer in mice via repressing neovascularization to impel necrosis of the tumor.

Key words: Realgar nanoparticle, Murine orthotopic transplanted breast cancer, Optical in vivo imaging

中图分类号:

R965.2

席晓霞, 范临兰, 田永刚, 王蓓, 张景科, 程杰, 魏虎来, 吴润. 纳米雄黄的抗小鼠原位乳腺癌作用及其机制[J]. 中国临床药理学与治疗学, 2013, 18(9): 981-987.

XI Xiao-xia, FAN Lin-lan, TIAN Yong-gang, WANG Bei, ZHANG Jing-ke, CHENG Jie, WEI Hu-lai, WU Run. The anti-tumor effects and mechanism of Realgar nanoparticles on orthotopic breast cancer in mice[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2013, 18(9): 981-987.

参考文献

[1] Wu J, Shao Y, Liu J, et al. The medicinal use of realgar (As4S4) and its recent development as an anticancer agent[J]. J Ethnopharmacol, 2011, 135(3): 595-602.
[2] Liu J, Lu Y, Wu Q, et al. Mineral arsenicals in traditional medicines: Orpiment, realgar, and arsenolite[J]. J Pharmacol Exp Ther, 2008, 326(2): 363-368.
[3] Man S, Gao W, Wei C, et al. Anticancer drugs from traditional toxic Chinese medicines[J]. Phytother Res, 2012, 26(10):1449-1465.
[4] 张景红, 李红玉. 雄黄微生物提取液对K562/ADM细胞P-糖蛋白和多药耐药基因表达的影响[J]. 中国临床药理学与治疗学, 2009, 14(8): 855-860.
[5] An YL, Nie F, Wang ZY, et al. Preparation and characterization of realgar nanoparticles and their inhibitory effect on rat glioma cells[J]. Int J Nanomedicine, 2011, 6: 3187-3194.
[6] 王晓波, 袭荣刚, 李忠亮, 等. 纳米级雄黄粉体的制备[J]. 解放军药学学报, 2002, 18(3): 129-133.
[7] 杨玥,易娟,陈静,等. 纳米雄黄对肺癌A549细胞的凋亡诱导作用[J]. 亚太传统医药,2010, 6(6): 8-11.
[8] 王永胜,易娟,陈静,等. 纳米雄黄对耐药性白血病细胞的凋亡诱导作用[J]. 中药药理与临床,2010, 26(5): 33-36.
[9] 杨玥,易娟,陈静,等. 纳米雄黄对肺癌A549细胞及其肿瘤干细胞的凋亡诱导作用[J]. 中药药理与临床,2010,26(6): 36-39.
[10] Rosenthal EL, Kullbersh BD, King T, et al. Use of fluorescent labeled anti-epidermal growth factor receptor antibody to image head and neck squamous cell carcinoma xenografts [J]. Mol Cancer Ther, 2007, 6(4): 1230-1238.
[11] Minn AJ, Gupta GP, Siegel PM, et al. Genes that mediate breast cancer metastasis to lung[J]. Nature, 2005, 436(7050): 518-524.
[12] 王晓敏,闺明霞,梁琳慧, 等. GFP和Luc双标技术在小鼠肿瘤模型建立中的应用[J]. 实验动物与比较医学,2010, 30(1):2-7.
[13] 李艳,张海燕,王喆,等. 通过活体动物光学成像系统建立乳腺癌动物模型[J]. 肿瘤,2009, 29(1):76-80.
[14] 郝钢跃,张维东,张月英,等. 浅表性膀胱癌模型的建立及其活体荧光成像[J]. 中国肿瘤防治杂志,2009, 16(24):1932-1934.
[15] 叶晓川,杨祥良,徐辉碧. 纳米雄黄研究进展[J]. 化学进展,2009, 21(5):934-939.